3.連結財務諸表及び主な注記

(1)連結貸借対照表

 

 

(単位:千円)

 

前連結会計年度

(2025年3月31日)

当連結会計年度

(2026年3月31日)

資産の部

 

 

流動資産

 

 

現金及び預金

154,663

357,200

受取手形及び売掛金

233,472

137,865

商品及び製品

751,925

674,560

仕掛品

22,137

原材料及び貯蔵品

57,355

56,999

預け金

179,083

未収入金

587

244,225

前払金

104,417

141,294

短期貸付金

133,000

暗号資産

154,154

その他

39,596

69,475

貸倒引当金

2,980

133,955

流動資産合計

1,540,257

1,834,820

固定資産

 

 

有形固定資産

 

 

建物及び構築物

278,833

32,338

減価償却累計額

96,011

30,802

建物及び構築物(純額)

182,821

1,536

機械装置及び運搬具

260,130

29,852

減価償却累計額

130,241

27,536

機械装置及び運搬具(純額)

129,888

2,315

工具、器具及び備品

213,551

192,784

減価償却累計額

176,473

186,053

工具、器具及び備品(純額)

37,078

6,731

土地

551,097

499,999

建設仮勘定

524,032

有形固定資産合計

1,424,918

510,582

無形固定資産

 

 

のれん

241,056

ソフトウエア

6,209

4,664

その他

161

89

無形固定資産合計

247,428

4,753

投資その他の資産

 

 

関係会社株式

138,521

長期未収入金

132,741

141,939

敷金及び保証金

36,499

37,899

その他

16,334

330

貸倒引当金

145,891

141,939

投資その他の資産合計

39,684

176,752

固定資産合計

1,712,030

692,089

資産合計

3,252,288

2,526,909

 

 

 

 

(単位:千円)

 

前連結会計年度

(2025年3月31日)

当連結会計年度

(2026年3月31日)

負債の部

 

 

流動負債

 

 

支払手形及び買掛金

182,128

146,937

短期借入金

95,000

250,000

1年内返済予定の長期借入金

41,786

未払金

118,451

138,932

未払法人税等

6,958

8,071

契約負債

5,880

6,604

賞与引当金

17,180

17,065

資産除去債務

16,348

その他

74,095

42,603

流動負債合計

557,829

610,214

固定負債

 

 

長期借入金

156,606

繰延税金負債

12,823

資産除去債務

10,389

10,573

その他

39,762

300

固定負債合計

219,581

10,873

負債合計

777,410

621,088

純資産の部

 

 

株主資本

 

 

資本金

1,851,763

2,214,855

資本剰余金

2,912,688

3,275,780

利益剰余金

2,308,176

3,584,814

株主資本合計

2,456,275

1,905,821

新株予約権

18,601

純資産合計

2,474,877

1,905,821

負債純資産合計

3,252,288

2,526,909

 

E0567438400パス株式会社PATH corporation通期第1号参考様式 [日本基準](連結)Japan GAAPtrueCTECTE2025-04-012026-03-31FY2026-03-312024-04-012025-03-312025-03-311falsefalsefalse384002024-04-012025-03-31tse-acedjpfr-38400:CosmeticsBusinessReportableSegmentsMember384002024-04-012025-03-31tse-acedjpfr-38400:BeautyAndWellnessBusinessReportableSegmentsMember384002024-04-012025-03-31tse-acedjpfr-38400:MarketExpansionBusinessReportableSegmentsMember384002024-04-012025-03-31tse-acedjpfr-38400:InvestmentBusinessReportableSegmentsMember384002025-04-012026-03-31tse-acedjpfr-38400:AITechnologyReportableSegmentsMember384002024-04-012025-03-31tse-acedjpfr-38400:AITechnologyReportableSegmentsMember384002026-03-31jppfs_cor:ShareholdersEquityMember384002026-03-31jppfs_cor:CapitalStockMember384002026-03-31jppfs_cor:CapitalSurplusMember384002026-03-31jppfs_cor:RetainedEarningsMember384002026-03-31jppfs_cor:SubscriptionRightsToSharesMember384002025-04-012026-03-31jppfs_cor:CapitalStockMember384002025-04-012026-03-31jppfs_cor:CapitalSurplusMember384002025-04-012026-03-31jppfs_cor:RetainedEarningsMember384002025-04-012026-03-31jppfs_cor:SubscriptionRightsToSharesMember384002024-04-012025-03-31jppfs_cor:CapitalStockMember384002024-04-012025-03-31jppfs_cor:CapitalSurplusMember384002026-05-13384002026-03-31384002025-04-012026-03-31384002025-03-31384002024-04-012025-03-31384002024-03-31384002025-04-012026-03-31jpcrp_cor:ReportableSegmentsMember384002024-04-012025-03-31jpcrp_cor:ReportableSegmentsMember384002025-04-012026-03-31tse-acedjpfr-38400:RegenerativeMedicineRelatedBusinessReportableSegmentsMember384002025-04-012026-03-31tse-acedjpfr-38400:SustainableBusinessReportableSegmentsMember384002024-04-012025-03-31tse-acedjpfr-38400:RegenerativeMedicineRelatedBusinessReportableSegmentsMember384002024-04-012025-03-31tse-acedjpfr-38400:SustainableBusinessReportableSegmentsMember384002025-04-012026-03-31jpcrp_cor:ReconcilingItemsMember384002024-04-012025-03-31jpcrp_cor:ReconcilingItemsMember384002025-04-012026-03-31tse-acedjpfr-38400:CosmeticsBusinessReportableSegmentsMember384002025-04-012026-03-31tse-acedjpfr-38400:BeautyAndWellnessBusinessReportableSegmentsMember384002025-04-012026-03-31tse-acedjpfr-38400:MarketExpansionBusinessReportableSegmentsMember384002025-04-012026-03-31tse-acedjpfr-38400:InvestmentBusinessReportableSegmentsMember384002024-04-012025-03-31jppfs_cor:ShareholdersEquityMember384002024-04-012025-03-31jppfs_cor:SubscriptionRightsToSharesMember384002025-03-31jppfs_cor:CapitalStockMember384002025-03-31jppfs_cor:CapitalSurplusMember384002025-03-31jppfs_cor:RetainedEarningsMember384002025-03-31jppfs_cor:ShareholdersEquityMember384002024-03-31jppfs_cor:CapitalStockMember384002024-03-31jppfs_cor:CapitalSurplusMember384002024-03-31jppfs_cor:RetainedEarningsMember384002024-03-31jppfs_cor:ShareholdersEquityMember384002024-03-31jppfs_cor:SubscriptionRightsToSharesMember384002024-04-012025-03-31jppfs_cor:RetainedEarningsMember384002025-04-012026-03-31jppfs_cor:ShareholdersEquityMember384002025-03-31jppfs_cor:SubscriptionRightsToSharesMemberxbrli:pureiso4217:JPY